ECX — Epigenomics AG Share News
0.000.00%
Last trade - 00:00- €0.61m
- -€2.62m
- €0.49m
Brief: BaFin Imposes Administrative Fine On Epigenomics
Brief: Epigenomics Completes Capital Increase
Brief: Epigenomics Q1 Net Loss At EUR -1.2 Mln
Brief: Epigenomics To Increase Share Capital Through Rights Issue
Brief: Epigenomics Announces Conversion Result Of First Conversion Period Of Mandatory Convertible Bond 2021/2024
Brief: Epigenomics FY Net Loss Narrows To EUR 11.7 Million
Brief: Epigenomics Is Evaluating M&A Options
Brief: Epigenomics Places Mandatory Convertible Bond Of EUR 5.5 Million
Brief: Epigenomics Plans To Challenge NCD Decision And Unveils Its Next Generation Liquid Biopsy Test
Brief: Epigenomics Says U.S. Centers For Medicare & Medicaid Services Issued Negative Reimbursement Decision For Epi Procolon
Brief: Epigenomics Issues Mandatory Convertible Bond Of Up To EUR 5.5 Mln
Brief: Epigenomics 9-mth Adj. EBITDA At EUR -8.1 Mln
Brief: Epigenomics Plans Capital Reduction And To Issue Convertible Bonds
Brief: Epigenomics Says Cumulative Loss Of More Than Half Of Nominal Share Capital Of Co Has Been Incurred
Brief: CMS Publish Negative Proposed Ncd For Epi Procolon
Brief: Epigenomics: CMS Still Working On Proposed Decision Memo With Goal To Publish As Soon As Possible
Brief: Epigenomics H1 Net Loss Narrows To EUR 6.4 Million
Brief: Epigenomics: Epi ProColon(R) Test Of Choice For Millions Not Willing To Participate In Fit Or Colonoscopy Screening
Brief: Epigenomics Confirms Its 2020 Outlook